Authors’ Reply to Yusuf Ziya Sener: “Regorafenib-Induced Hypothyroidism as a Predictive Marker for Improved Survival in Metastatic or Unresectable Colorectal Cancer Refractory to Standard Therapies: A Prospective Single-Center Study”

Authors’ Reply to Yusuf Ziya Sener: “Regorafenib-Induced Hypothyroidism as a Predictive Marker for Improved Survival in Metastatic or Unresectable Colorectal Cancer Refractory to Standard Therapies: A Prospective Single-Center Study”

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Targeted oncology 2020-06, Vol.15 (3), p.413-414
Hauptverfasser: Kim, Jwa Hoon, Kim, Jeong Eun, Hong, Yong Sang
Format: Artikel
Sprache:eng
Schlagworte:
Biomedicine
Letter to the Editor
Medicine
Medicine & Public Health
Oncology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 414
container_issue 3
container_start_page 413
container_title Targeted oncology
container_volume 15
creator Kim, Jwa Hoon
Kim, Jeong Eun
Hong, Yong Sang
description
doi_str_mv 10.1007/s11523-020-00726-w
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2407582735</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2407582735</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-2d3edb2ac2765a7e802cfc8032a671d6c732f4ad205e46df61ea845393d03e5d3</originalsourceid><addsrcrecordid>eNp9ks9uEzEQxlcIREvhBTggS1y4LPjPrjfpLYqARmoFSloJuKwm9mzisrEX25tqb30NJHi5vACvgNu0IHHgZI_8-76Zkb8se87oa0Zp9SYwVnKRU07zVHKZXz3IDllVyZxL-unh_b0cy4PsSQiXlBYVL-nj7EDwQnLBxofZr0kf186H3fV3MseuHUh05HMf-oZ8MQOQBVr0x2R3_WOOK-ehQWuW-czqXqEmJ0Pn4nrwzmgTNgQCAfLRozYqmi2SM_Bf0ZPGeTLbdN5tk2TR-63ZQkuMJWcYIUSIRpGEXFiPAVWEZYtk6lrnb4qWTMGq5DLHxoOKzt-OuIhgNXhNztfooTMYjskk9Xahw33zhbGrFvMp2pjUi9jrYXf982n2qIE24LO78yi7ePf2fHqSn354P5tOTnMluIw51wL1koPilSyhwhHlqlEjKjjIimmpKsGbAjSnJRZSN5IhjIpSjIWmAkstjrJXe9-09rceQ6w3JihsW7Do-lDzglbliFeiTOjLf9BL13ubpksUY7RkomCJ4ntKpR2Dx6buvNmAH2pG65s41Ps41CkO9W0c6qskenFn3S83qP9I7v8_AWIPhPRkV-j_9v6P7W-iu8iY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2411051341</pqid></control><display><type>article</type><title>Authors’ Reply to Yusuf Ziya Sener: “Regorafenib-Induced Hypothyroidism as a Predictive Marker for Improved Survival in Metastatic or Unresectable Colorectal Cancer Refractory to Standard Therapies: A Prospective Single-Center Study”</title><source>SpringerLink Journals</source><creator>Kim, Jwa Hoon ; Kim, Jeong Eun ; Hong, Yong Sang</creator><creatorcontrib>Kim, Jwa Hoon ; Kim, Jeong Eun ; Hong, Yong Sang</creatorcontrib><identifier>ISSN: 1776-2596</identifier><identifier>EISSN: 1776-260X</identifier><identifier>DOI: 10.1007/s11523-020-00726-w</identifier><identifier>PMID: 32462319</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Biomedicine ; Letter to the Editor ; Medicine ; Medicine &amp; Public Health ; Oncology</subject><ispartof>Targeted oncology, 2020-06, Vol.15 (3), p.413-414</ispartof><rights>Springer Nature Switzerland AG 2020</rights><rights>Springer Nature Switzerland AG 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c326t-2d3edb2ac2765a7e802cfc8032a671d6c732f4ad205e46df61ea845393d03e5d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11523-020-00726-w$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11523-020-00726-w$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32462319$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kim, Jwa Hoon</creatorcontrib><creatorcontrib>Kim, Jeong Eun</creatorcontrib><creatorcontrib>Hong, Yong Sang</creatorcontrib><title>Authors’ Reply to Yusuf Ziya Sener: “Regorafenib-Induced Hypothyroidism as a Predictive Marker for Improved Survival in Metastatic or Unresectable Colorectal Cancer Refractory to Standard Therapies: A Prospective Single-Center Study”</title><title>Targeted oncology</title><addtitle>Targ Oncol</addtitle><addtitle>Target Oncol</addtitle><subject>Biomedicine</subject><subject>Letter to the Editor</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Oncology</subject><issn>1776-2596</issn><issn>1776-260X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNp9ks9uEzEQxlcIREvhBTggS1y4LPjPrjfpLYqARmoFSloJuKwm9mzisrEX25tqb30NJHi5vACvgNu0IHHgZI_8-76Zkb8se87oa0Zp9SYwVnKRU07zVHKZXz3IDllVyZxL-unh_b0cy4PsSQiXlBYVL-nj7EDwQnLBxofZr0kf186H3fV3MseuHUh05HMf-oZ8MQOQBVr0x2R3_WOOK-ehQWuW-czqXqEmJ0Pn4nrwzmgTNgQCAfLRozYqmi2SM_Bf0ZPGeTLbdN5tk2TR-63ZQkuMJWcYIUSIRpGEXFiPAVWEZYtk6lrnb4qWTMGq5DLHxoOKzt-OuIhgNXhNztfooTMYjskk9Xahw33zhbGrFvMp2pjUi9jrYXf982n2qIE24LO78yi7ePf2fHqSn354P5tOTnMluIw51wL1koPilSyhwhHlqlEjKjjIimmpKsGbAjSnJRZSN5IhjIpSjIWmAkstjrJXe9-09rceQ6w3JihsW7Do-lDzglbliFeiTOjLf9BL13ubpksUY7RkomCJ4ntKpR2Dx6buvNmAH2pG65s41Ps41CkO9W0c6qskenFn3S83qP9I7v8_AWIPhPRkV-j_9v6P7W-iu8iY</recordid><startdate>20200601</startdate><enddate>20200601</enddate><creator>Kim, Jwa Hoon</creator><creator>Kim, Jeong Eun</creator><creator>Hong, Yong Sang</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20200601</creationdate><title>Authors’ Reply to Yusuf Ziya Sener: “Regorafenib-Induced Hypothyroidism as a Predictive Marker for Improved Survival in Metastatic or Unresectable Colorectal Cancer Refractory to Standard Therapies: A Prospective Single-Center Study”</title><author>Kim, Jwa Hoon ; Kim, Jeong Eun ; Hong, Yong Sang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-2d3edb2ac2765a7e802cfc8032a671d6c732f4ad205e46df61ea845393d03e5d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Biomedicine</topic><topic>Letter to the Editor</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Oncology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, Jwa Hoon</creatorcontrib><creatorcontrib>Kim, Jeong Eun</creatorcontrib><creatorcontrib>Hong, Yong Sang</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Targeted oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, Jwa Hoon</au><au>Kim, Jeong Eun</au><au>Hong, Yong Sang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Authors’ Reply to Yusuf Ziya Sener: “Regorafenib-Induced Hypothyroidism as a Predictive Marker for Improved Survival in Metastatic or Unresectable Colorectal Cancer Refractory to Standard Therapies: A Prospective Single-Center Study”</atitle><jtitle>Targeted oncology</jtitle><stitle>Targ Oncol</stitle><addtitle>Target Oncol</addtitle><date>2020-06-01</date><risdate>2020</risdate><volume>15</volume><issue>3</issue><spage>413</spage><epage>414</epage><pages>413-414</pages><issn>1776-2596</issn><eissn>1776-260X</eissn><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>32462319</pmid><doi>10.1007/s11523-020-00726-w</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1776-2596
ispartof Targeted oncology, 2020-06, Vol.15 (3), p.413-414
issn 1776-2596
1776-260X
language eng
recordid cdi_proquest_miscellaneous_2407582735
source SpringerLink Journals
subjects Biomedicine
Letter to the Editor
Medicine
Medicine & Public Health
Oncology
title Authors’ Reply to Yusuf Ziya Sener: “Regorafenib-Induced Hypothyroidism as a Predictive Marker for Improved Survival in Metastatic or Unresectable Colorectal Cancer Refractory to Standard Therapies: A Prospective Single-Center Study”
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T08%3A45%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Authors%E2%80%99%20Reply%20to%20Yusuf%20Ziya%20Sener:%20%E2%80%9CRegorafenib-Induced%20Hypothyroidism%20as%20a%20Predictive%20Marker%20for%20Improved%20Survival%20in%20Metastatic%20or%20Unresectable%20Colorectal%20Cancer%20Refractory%20to%20Standard%20Therapies:%20A%20Prospective%20Single-Center%20Study%E2%80%9D&rft.jtitle=Targeted%20oncology&rft.au=Kim,%20Jwa%20Hoon&rft.date=2020-06-01&rft.volume=15&rft.issue=3&rft.spage=413&rft.epage=414&rft.pages=413-414&rft.issn=1776-2596&rft.eissn=1776-260X&rft_id=info:doi/10.1007/s11523-020-00726-w&rft_dat=%3Cproquest_cross%3E2407582735%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2411051341&rft_id=info:pmid/32462319&rfr_iscdi=true